Effect of pregnancy on HbA2 value in women with heterozygous β- thalassemia
Year 2019,
Volume: 44 Issue: 1, 274 - 275, 31.03.2019
Gülüzar Özbolat
References
- 1. Özbolat G. Tuli A. Talasemi ve ilgili hemoglobinopatilerin Moleküler Tanı Yöntemleri: Günümüz ve Gelecek. Adıyaman Üni. Sağlık Bilimleri Derg, 2017;3(3):599-616.
- 2. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9.
- 3. Özbolat G. Tuli A. Hematologic features of beta-globin gene mutation type (βo) with homozygous beta thalassemia. Ukr. Biochem. J., 2018, 90,4.
- 4. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9.
- 5. Menzel S, Garner C, Rooks H, Spector TD, Thein SL. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol. 2013;160(1):101-5.
- 6. Șeicaru D. Constantinescu D. Corina F. Bulucea D. Heterozygous Beta-thalassemia, a Genetic Haemolytic Anaemia in Continuous Expansion. Acta Medica Marisiensis 2013;59(2):154-157.
- 7. Kneifati-Hayek, J. Fleischman W. Bernstein LH. Riccioli A. Bellevue R. A model for automated screening of thalassemia in hematology (math study). Lab. Hematol., 2007;13, 119- 123.
- 8. Giambona A, Passarello C, Renda D, Maggio A. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786-96.
- 9. Özbolat G. Yılmaz N. Döğüş Y. Tuli A. The pregnancy variable in women with heterozygous beta thalassemia. Ejpmr, 2018,5(4), 98-100.
Heterozigot β-talasemili kadınlarda gebelik değişkeninin HbA2 değeri üzerine etkisi
Year 2019,
Volume: 44 Issue: 1, 274 - 275, 31.03.2019
Gülüzar Özbolat
References
- 1. Özbolat G. Tuli A. Talasemi ve ilgili hemoglobinopatilerin Moleküler Tanı Yöntemleri: Günümüz ve Gelecek. Adıyaman Üni. Sağlık Bilimleri Derg, 2017;3(3):599-616.
- 2. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9.
- 3. Özbolat G. Tuli A. Hematologic features of beta-globin gene mutation type (βo) with homozygous beta thalassemia. Ukr. Biochem. J., 2018, 90,4.
- 4. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9.
- 5. Menzel S, Garner C, Rooks H, Spector TD, Thein SL. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol. 2013;160(1):101-5.
- 6. Șeicaru D. Constantinescu D. Corina F. Bulucea D. Heterozygous Beta-thalassemia, a Genetic Haemolytic Anaemia in Continuous Expansion. Acta Medica Marisiensis 2013;59(2):154-157.
- 7. Kneifati-Hayek, J. Fleischman W. Bernstein LH. Riccioli A. Bellevue R. A model for automated screening of thalassemia in hematology (math study). Lab. Hematol., 2007;13, 119- 123.
- 8. Giambona A, Passarello C, Renda D, Maggio A. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786-96.
- 9. Özbolat G. Yılmaz N. Döğüş Y. Tuli A. The pregnancy variable in women with heterozygous beta thalassemia. Ejpmr, 2018,5(4), 98-100.
There are 9 citations in total.